Petadolex 75 mg
Natural health product licensed in Canada
- Other names
- Petadolex 75
- Licence holder
- Linpharma Inc.
- NPN or DIN-HM
- 80107351
- Status
- Active licence
- Licence date
- 18 January 2021
- Revision date
- 27 December 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Petasites hybridus Source : Rhizome Extract : Matériel brut sec Extraction ratio : 36:1 Dry plant equivalent : 2,700 mg Potency : 11.25 mg Petasin & Isopetasin | 75 mg | Not calculated |
Non-medicinal ingredients
Glycérol, Huile d'olive, Sorbitol, Gélatine, NA, Eau purifiée, Carotènes mélangées
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Helps to reduce the frequency of migraine headaches when taken preventatively/as a prophylactic.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking any other natural health products, prescription medications or if you have a medical condition. Consult a health care practitioner if migraine frequency increases and associated nausea and vomiting persist or worsen. Keep out of reach of children.
- Contre-indications
Do not use 1) if you are pregnant or breastfeeding 2) if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Not suitable for people with hepatitis and/or chronic alcohol abuse. Stop use and consult a health care practitioner if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite. Do not use if you have any liver disease.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur, in which case, discontinue use.
Source
Official Health Canada record, licence 80107351
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging